• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHB2201574 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2022-09-02 Hebei Changshan Biochemical Pharmaceutical Co Ltd view
CYHB2302043 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2023-09-11 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
JYHB2200132 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-03-15 Sanofi-Aventis France;Sanofi Winthrop Industrie view
CYHB2400559 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
JYHB2200512 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-09-17 Sanofi-Aventis France;Sanofi Winthrop Industrie view
B20000117 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Import Drug Application 2000-01-01 view
CYHB2200984 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2022-06-16 Shenzhen Techdow Pharmaceutical Co Ltd view
CYHB2150505 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(原6) Supplementary Application 2021-02-21 Dongying Tiandong Pharmaceutical Co Ltd view
CYHS2201115 肝素钠注射液 Heparin Sodium Injection Chemical Drugs(3) Generic Drug 2022-07-21 Yantai Dongcheng Beifang Pharmaceutical Co Ltd;Guangdong Sunho Pharmaceutical Co Ltd view
JYHZ2400221 贝米肝素钠注射液 bemiparin sodium Injection Chemical Drugs(5.1) License Renew 2024-08-13 Hi Nice Shine Pharmaceutical Inc;Laboratorios Farmacéuticos ROVI;ROVI Pharma Industrial Services S.A view
CYHS2101476 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(4) Generic Drug 2021-07-27 Suzhou Erye Pharmaceutical Co Ltd view
CYHB2300615 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(4) Supplementary Application 2023-03-24 Suzhou Erye Pharmaceutical Co Ltd view
JYHB2200206 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-04-12 Sanofi-Aventis France;Sanofi Winthrop Industrie view
CYHB2450062 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(原6) Supplementary Application 2024-01-23 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd view
CYHB2500218 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs(4) Supplementary Application 2025-01-27 Yantai Dongcheng Beifang Pharmaceutical Co Ltd view
JYHB2200134 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-03-15 Sanofi-Aventis France;Sanofi Winthrop Industrie view
CYHB2350562 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Supplementary Application 2023-07-13 QILU Pharmaceutical Co Ltd view
CYHB2240041 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2022-11-22 Changzhou Qianhong Biopharma Co Ltd view
JYHZ2400028 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
CYHB2302042 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2023-09-11 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view